We are joined by Deb Wells, CEO of the Wells Health Group, a health policy consulting firm located in Washington, DC. WHG was founded in 2012 to help clients develop and execute successful health policy strategies to maximize enterprise value.

Deb Wells is a reimbursement and market access expert who covers all things BioWavePENS reimbursement, including coding 64999, coverage criteria, payment methodologies, and denials/appeals.